ST6GAL2 Gene Beta-Galactosamide Alpha-2,6-Sialyltransferase 2 Deficiency NGS Genetic DNA Test
Comprehensive Genetic Analysis for Metabolic Health
The ST6GAL2 Gene Beta-Galactosamide Alpha-2,6-Sialyltransferase 2 Deficiency NGS Genetic DNA Test represents a breakthrough in precision medicine for metabolic disorders. This advanced diagnostic tool specifically targets the ST6GAL2 gene, which encodes a crucial enzyme involved in sialylation processes essential for proper cellular communication and neurological function.
What This Test Measures and Detects
Our comprehensive NGS genetic test analyzes the complete coding region of the ST6GAL2 gene to identify:
- Point mutations and single nucleotide variants
- Insertions and deletions affecting gene function
- Copy number variations impacting enzyme production
- Regulatory region mutations affecting gene expression
- Pathogenic variants linked to metabolic dysfunction
Who Should Consider This Genetic Test
This specialized genetic analysis is recommended for individuals presenting with:
- Unexplained neurological symptoms including seizures or movement disorders
- Developmental delays in childhood or adolescence
- Metabolic abnormalities detected through routine screening
- Family history of inherited metabolic disorders
- Unexplained glycosylation defects in previous testing
- Consanguineous parentage with metabolic concerns
Clinical Benefits of ST6GAL2 Genetic Testing
Undergoing this comprehensive genetic analysis provides numerous clinical advantages:
- Accurate Diagnosis: Precise identification of ST6GAL2 gene mutations enables targeted treatment approaches
- Family Planning Guidance: Genetic counseling based on test results supports informed reproductive decisions
- Personalized Treatment: Test outcomes guide development of individualized therapeutic strategies
- Proactive Health Management: Early detection allows for preventive interventions and monitoring
- Research Contribution: Participation advances scientific understanding of metabolic disorders
Understanding Your Test Results
Our comprehensive genetic report provides clear, actionable information:
- Positive Result: Indicates the presence of pathogenic ST6GAL2 variants requiring specialized medical management
- Negative Result: Suggests absence of known disease-causing mutations in the analyzed gene regions
- Variant of Uncertain Significance: Identifies genetic changes requiring further clinical correlation
- Carrier Status: Determines inheritance patterns for family risk assessment
Test Pricing Information
| Test Component | Price (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Nationwide Testing Availability
We maintain comprehensive testing facilities across the United States, with specialized genetic testing centers in:
- New York City, NY
- Los Angeles, CA
- Chicago, IL
- Houston, TX
- Phoenix, AZ
- Philadelphia, PA
- San Antonio, TX
- San Diego, CA
- Dallas, TX
- San Jose, CA
Take Control of Your Metabolic Health Today
Don’t let uncertainty about genetic metabolic conditions affect your quality of life. Our ST6GAL2 Gene Deficiency NGS Genetic DNA Test provides the clarity needed for informed healthcare decisions. With results available in 3-4 weeks and multiple sample collection options including blood, extracted DNA, or FTA card blood spots, accessing this vital genetic information has never been more convenient.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic counseling session and book your comprehensive ST6GAL2 genetic analysis. Our expert genetic counselors are ready to guide you through the testing process and help you understand your results for better metabolic health management.
